Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression Post author:Sam Post published:November 8, 2017 Post category:BioPharma The positive results support the company’s planned regulatory submissions. Source: BioSpace You Might Also Like Exiting Novartis AG CEO Sets His Sights on Silicon Valley and Its Biotech Startups September 7, 2017 Publication Of Prospectus Relating To The Listing Of On Six Swiss Exchange June 8, 2017 Germany's Evotec AG Plans to Hire Scientists and Execs at New U.S. HQ May 29, 2017
